{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:19:39Z","timestamp":1791494379433,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011086","name":"NASPGHAN Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jlr.2022.100324","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T19:55:09Z","timestamp":1672257309000},"page":"100324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic steatosis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4217-8264","authenticated-orcid":false,"given":"Francois","family":"Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Brasil","family":"Brunao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-3946","authenticated-orcid":false,"given":"Julian","family":"Avila-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Softic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100324_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100324_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2022.100324_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH Leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jlr.2022.100324_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100324_bib5","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2022.100324_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-2275(20)41693-1","article-title":"Cholesterol 7 alpha-hydroxylase","volume":"18","author":"Myant","year":"1977","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100324_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","article-title":"Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis","volume":"72","author":"Siddiqui","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100324_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct Target Ther."},{"key":"10.1016\/j.jlr.2022.100324_bib9","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/j.1460-2075.1990.tb07454.x","article-title":"Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors","volume":"9","author":"Dionne","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.jlr.2022.100324_bib10","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.87.22.8913","article-title":"Putative tyrosine kinases expressed in K-562 human leukemia cells","volume":"87","author":"Partanen","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100324_bib11","first-page":"1195","article-title":"Alternative splicing generates at least five different isoforms of the human basic-FGF receptor","volume":"6","author":"Eisemann","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.jlr.2022.100324_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.1846977","article-title":"Fibroblast growth factor receptors from liver vary in three structural domains","volume":"251","author":"Hou","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jlr.2022.100324_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.89.1.246","article-title":"Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene","volume":"89","author":"Miki","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100324_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060614","article-title":"Fibroblast Growth Factor Receptors (FGFRs): structures and small molecule inhibitors","volume":"8","author":"Dai","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2022.100324_bib15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jlr.2022.100324_bib16","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1074\/jbc.275.15.10918","article-title":"Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription","volume":"275","author":"Chiang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100324_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100324_bib18","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jlr.2022.100324_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000450981","article-title":"Intestinal farnesoid X receptor and takeda G protein couple receptor 5 signaling in metabolic regulation","volume":"35","author":"Chiang","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jlr.2022.100324_bib20","doi-asserted-by":"crossref","first-page":"30470","DOI":"10.1074\/jbc.M114.592022","article-title":"Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions","volume":"289","author":"Ge","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100324_bib21","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2337\/db07-0648","article-title":"FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2022.100324_bib22","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.0907812106","article-title":"Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob\/ob mice","volume":"106","author":"Wu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100324_bib23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/cb501028c","article-title":"siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in\u00a0vivo in hepatocytes","volume":"10","author":"Matsuda","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jlr.2022.100324_bib24","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jlr.2022.100324_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.jlr.2022.100324_bib26","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100324_bib27","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db16-0213","article-title":"Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD","volume":"65","author":"Softic","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2022.100324_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110277","article-title":"Tissue differences in the exosomal\/small extracellular vesicle proteome and their potential as indicators of altered tissue metabolism","volume":"38","author":"Garcia-Martin","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2022.100324_bib29","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100324_bib30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/gut.34.9.1219","article-title":"Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon","volume":"34","author":"Adrian","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jlr.2022.100324_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2014.12.009","article-title":"Palmitate induces insulin resistance in human HepG2 hepatocytes by enhancing ubiquitination and proteasomal degradation of key insulin signaling molecules","volume":"566","author":"Ishii","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jlr.2022.100324_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2016.04.002","article-title":"Low-density lipoprotein receptor-related protein-1 protects against hepatic insulin resistance and hepatic steatosis","volume":"7","author":"Ding","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jlr.2022.100324_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036713","article-title":"Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models","volume":"7","author":"French","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2022.100324_bib34","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jlr.2022.100324_bib35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jlr.2022.100324_bib36","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1074\/jbc.M307363200","article-title":"Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis","volume":"279","author":"Figge","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100324_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051399","article-title":"Dietary betaine addition promotes hepatic cholesterol synthesis, bile acid conversion, and export in rats","volume":"12","author":"Li","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jlr.2022.100324_bib38","article-title":"Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2022.100324_bib39","article-title":"IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery","volume":"2","author":"Faramia","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jlr.2022.100324_bib40","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/oby.2012.90","article-title":"Upregulation of plasma insulin-like growth factor binding protein 2 levels after biliopancreatic diversion in humans","volume":"20","author":"Li","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jlr.2022.100324_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/db06-0436","article-title":"IGF-binding protein-2 protects against the development of obesity and insulin resistance","volume":"56","author":"Wheatcroft","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2022.100324_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031133","article-title":"Potential role of insulin growth-factor-binding protein 2 as therapeutic target for obesity-related insulin resistance","volume":"22","author":"Boughanem","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2022.100324_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1520-7560(199909\/10)15:5<314::AID-DMRR56>3.0.CO;2-E","article-title":"Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes","volume":"15","author":"Frystyk","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.jlr.2022.100324_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cob.12245","article-title":"Serum IGFBP-2 levels are associated with reduced insulin sensitivity in obese children","volume":"8","author":"Yau","year":"2018","journal-title":"Clin. Obes."},{"key":"10.1016\/j.jlr.2022.100324_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.jlr.2022.100324_bib46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100324_bib47","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M306422200","article-title":"The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion","volume":"279","author":"Lew","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100324_bib48","doi-asserted-by":"crossref","first-page":"G996","DOI":"10.1152\/ajpgi.90343.2008","article-title":"beta-Klotho and FGF-15\/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes","volume":"295","author":"Sinha","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2022.100324_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jlr.2022.100324_bib50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100324_bib51","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2022.100324_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060536","article-title":"FGF19-FGFR4 signaling in hepatocellular carcinoma","volume":"8","author":"Raja","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2022.100324_bib53","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:31:30Z","timestamp":1758306690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0022227522001572"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100324","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic steatosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100324"}}